Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate vs Neostigmine as Adjuvant to Bupivacaine in TAP Block for Cesarean Section
NCT06513013Phase 3Completed
- Sponsor
- Assiut University
- Start
- Dec 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate, neostigmine in postoperative pain, sponsored by Assiut University. Started Dec 2023; status: completed.
02
Drugs
magnesium sulfateneostigmine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06513013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06513013.